Guidelines

PP71 Impact of Tofacitinib on xenogeneic graft versus host disease

February 2017
PP72 Transcription factors and checkpoint inhibitor expression with age: predictive markers of aging?

February 2017
PP73 Loss of transfer RNA U34 modifying enzymes impairs hematopoietic stem and progenitor cell differentiation and function

February 2017
PP74 Limited impact of imatinib in a murine model of sclerodermatous chronic graft-versus-host disease

February 2017
P06 Targeted single cell sequencing unravels the heterogeneity of human T-cell acute lymphoblastic leukemia samples

February 2017
P07 Unravelling oncogenic signalling induced by JAK3 mutations in a model of T-cell acute lymphoblastic leukemia (T-ALL)

February 2017
P08 Immunotherapy in Multiple Myeloma using alfa-galactosylceramide loaded sEVs from dendritic cells to stimulate NKT activity

February 2017
P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

February 2017
P10 The genetic landscape of the murine 5T models for multiple myeloma

February 2017
P11 Low-pass sequencing of plasma cell DNA and of circulating cell-free DNA for the detection of copy number aberrations and early response monitoring in multiple myeloma

February 2017

Top